Background: The Releaf AppTM mobile software application (app) data was used to measure self-reported effectiveness and side effects of medical cannabis used under naturalistic conditions.Methods: Between 5/03/2016 and 12/16/2017, 2,830 Releaf AppTM users completed 13,638 individual sessions self-administering medical cannabis and indicated their primary health symptom severity rating on an 11-point (0–10) visual analog scale in real-time prior to and following cannabis consumption, along with experienced side effects.Results: Releaf AppTM responders used cannabis to treat myriad health symptoms, the most frequent relating to pain, anxiety, and depressive conditions. Significant symptom severity reductions were reported for all the symptom ...
Introduction: Although cannabis is widely used for the treatment of chronic pain, most research reli...
OBJECTIVE: To investigate the impact of regular cannabis use on long-term remission of mood symptoms...
AimsPatients with chronic health conditions not responding to conventional treatment can access medi...
Background: The Releaf AppTM mobile software application (app) data was used to measure self-reporte...
Background: The Releaf AppTM mobile software application (app) data was used to measure self-reporte...
Background: The Releaf AppTM mobile software application (app) data was used to measure self-reporte...
Background: The Releaf AppTM mobile software application (app) data was used to measure self-reporte...
Introduction: There is a growing body of literature supporting the efficacy of cannabis-based medici...
OBJECTIVES: To explore pain-specific, general health-related quality of life (HRQoL), and safety out...
Background: We use a mobile software application (app) to measure for the first time, which fundamen...
Objectives: To characterize health-related quality of life (HRQoL) in medical cannabis patients. Met...
AIM: Cannabis-based medicinal products (CBMPs) are prescribed with increased frequency, despite a pa...
Therapeutic use of cannabinoids, the main active ingredients of Cannabissativa L., is often hindered...
Background: The aim of this study was to describe the patterns of cannabis use and the associated be...
Objectives: To characterize health-related quality of life (HRQoL) in medical cannabis patients. Met...
Introduction: Although cannabis is widely used for the treatment of chronic pain, most research reli...
OBJECTIVE: To investigate the impact of regular cannabis use on long-term remission of mood symptoms...
AimsPatients with chronic health conditions not responding to conventional treatment can access medi...
Background: The Releaf AppTM mobile software application (app) data was used to measure self-reporte...
Background: The Releaf AppTM mobile software application (app) data was used to measure self-reporte...
Background: The Releaf AppTM mobile software application (app) data was used to measure self-reporte...
Background: The Releaf AppTM mobile software application (app) data was used to measure self-reporte...
Introduction: There is a growing body of literature supporting the efficacy of cannabis-based medici...
OBJECTIVES: To explore pain-specific, general health-related quality of life (HRQoL), and safety out...
Background: We use a mobile software application (app) to measure for the first time, which fundamen...
Objectives: To characterize health-related quality of life (HRQoL) in medical cannabis patients. Met...
AIM: Cannabis-based medicinal products (CBMPs) are prescribed with increased frequency, despite a pa...
Therapeutic use of cannabinoids, the main active ingredients of Cannabissativa L., is often hindered...
Background: The aim of this study was to describe the patterns of cannabis use and the associated be...
Objectives: To characterize health-related quality of life (HRQoL) in medical cannabis patients. Met...
Introduction: Although cannabis is widely used for the treatment of chronic pain, most research reli...
OBJECTIVE: To investigate the impact of regular cannabis use on long-term remission of mood symptoms...
AimsPatients with chronic health conditions not responding to conventional treatment can access medi...